Advanced search
Publication Cover
Infection and Drug Resistance Volume 6, 2013 - Issue
Submit an article Journal homepage
203
Views
16
CrossRef citations to date
0
Altmetric
Review

Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination

Mai-Chi Hong1 Department of Pharmacy Practice and Administration, Western University of Health Sciences, Pomona, CA, USA
,
Donald I Hsu1 Department of Pharmacy Practice and Administration, Western University of Health Sciences, Pomona, CA, USA;2 Department of Pharmacy, St Joseph Hospital, Orange, CA, USA
&
Mark Bounthavong3 Department of Pharmacy, Veterans Affairs San Diego Healthcare System, San Diego, CA, USA;4 Department of Pharmacy Practice, University of California, San Diego, CA, USACorrespondence[email protected]
Pages 215-223 | Published online: 29 Nov 2013

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Paulina Paprocka, Bonita Durnaś, Angelika Mańkowska, Karol Skłodowski, Grzegorz Król, Magdalena Zakrzewska, Michał Czarnowski, Patrycja Kot, Kamila Fortunka, Stanisław Góźdź, Paul B Savage & Robert Bucki. (2021) New β-Lactam Antibiotics and Ceragenins – A Study to Assess Their Potential in Treatment of Infections Caused by Multidrug-Resistant Strains of Pseudomonas aeruginosa. Infection and Drug Resistance 14, pages 5681-5698.
Read now
Marguerite L. Monogue, Joseph L. Kuti & David P. Nicolau. (2016) Optimizing Antibiotic Dosing Strategies for the Treatment of Gram-negative Infections in the Era of Resistance. Expert Review of Clinical Pharmacology 9:3, pages 459-476.
Read now
Sergio Ramírez-Estrada, Bárbara Borgatta & Jordi Rello. (2016) Pseudomonas aeruginosa ventilator-associated pneumonia management. Infection and Drug Resistance 9, pages 7-18.
Read now
Travis M Jones, Steven W Johnson, V Paul DiMondi & Dustin T Wilson. (2016) Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. Infection and Drug Resistance 9, pages 119-128.
Read now
David P Nicolau. (2015) Focus on ceftazidime-avibactam for optimizing outcomes in complicated intra-abdominal and urinary tract infections. Expert Opinion on Investigational Drugs 24:9, pages 1261-1273.
Read now
Emilio Maseda, Lorenzo Aguilar, Maria-Jose Gimenez & Fernando Gilsanz. (2014) Ceftolozane/tazobactam (CXA 201) for the treatment of intra-abdominal infections. Expert Review of Anti-infective Therapy 12:11, pages 1311-1324.
Read now

Articles from other publishers (10)

Hiba Alaoui Mdarhri, Rachid Benmessaoud, Houda Yacoubi, Lina Seffar, Houda Guennouni Assimi, Mouhsine Hamam, Rihabe Boussettine, Najoie Filali-Ansari, Fatima Azzahra Lahlou, Idrissa Diawara, Moulay Mustapha Ennaji & Mohamed Kettani-Halabi. (2022) Alternatives Therapeutic Approaches to Conventional Antibiotics: Advantages, Limitations and Potential Application in Medicine. Antibiotics 11:12, pages 1826.
Crossref
Juan Carlos García-Betancur, Elsa De La Cadena, María F. Mojica, Cristhian Hernández-Gómez, Adriana Correa, Marcela A. Radice, Paulo Castañeda-Méndez, Diego A. Jaime-Villalon, Ana C. Gales, José M. Munita & María Virginia Villegas. (2022) Comparative In Vitro Activity of Ceftolozane/Tazobactam against Clinical Isolates of Pseudomonas aeruginosa and Enterobacterales from Five Latin American Countries. Antibiotics 11:8, pages 1101.
Crossref
María Milagro Montero, Sandra Domene-Ochoa, Carla López-Causapé, Inmaculada López-Montesinos, Sonia Luque, Luisa Sorlí, Núria Campillo, Eduardo Padilla, Núria Prim, Lorena Ferrer Alapont, Santiago Grau, Antonio Oliver & Juan P. Horcajada. (2022) Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates. Microbiology Spectrum 10:3.
Crossref
Shio-Shin Jean, Dorji Harnod & Po-Ren Hsueh. (2022) Global Threat of Carbapenem-Resistant Gram-Negative Bacteria. Frontiers in Cellular and Infection Microbiology 12.
Crossref
María M. Montero, Sandra Domene-Ochoa, Carla López-Causapé, Sonia Luque, Luisa Sorlí, Núria Campillo, Eduardo Padilla, Núria Prim, Lorena Ferrer-Alapont, Ariadna Angulo-Brunet, Santiago Grau, Antonio Oliver & Juan P. Horcajada. (2021) Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber infection model. Scientific Reports 11:1.
Crossref
Olha A. Poda, Tetyana O. Kryuchko, Inna N. Nesina, Olha Ya. Tkachenko & Nataliia V. Kuzmenko. (2019) MODERN APPROACHES TO TREATMENT OF PSEUDOMONAS AERUGINOSA VENTILATOR-ASSOCIATED PNEUMONIA (LITERATURE REVIEW). Wiadomości Lekarskie 72:5, pages 892-896.
Crossref
Jocelyn Y. Ang, Nahed Abdel-Haq, Frank Zhu, Abrar K. Thabit, David P. Nicolau, Michael J. Satlin & David van Duin. (2016) Multidrug-Resistant Pseudomonas aeruginosa Infection in a Child with Cystic Fibrosis. Antimicrobial Agents and Chemotherapy 60:10, pages 5627-5630.
Crossref
Neelam YanejaHarsimran Kaur. (2016) Insights into Newer Antimicrobial Agents against Gram-negative Bacteria. Microbiology Insights 9, pages MBI.S29459.
Crossref
Gauri G. Rao, Neang S. Ly, Brian T. Tsuji, Jürgen B. Bulitta & Alan Forrest. 2016. Systems Pharmacology and Pharmacodynamics. Systems Pharmacology and Pharmacodynamics 371 402 .
Xian-Zhi Li & Patrick Plésiat. 2016. Efflux-Mediated Antimicrobial Resistance in Bacteria. Efflux-Mediated Antimicrobial Resistance in Bacteria 359 400 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.